142 related articles for article (PubMed ID: 17090564)
1. MHC2TA is associated with rheumatoid arthritis in Japanese patients.
Iikuni N; Ikari K; Momohara S; Tomatsu T; Hara M; Yamanaka H; Okamoto H; Kamatani N
Ann Rheum Dis; 2007 Feb; 66(2):274-5. PubMed ID: 17090564
[No Abstract] [Full Text] [Related]
2. MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.
Mendoza Rincón JF; Rodríguez Elias AK; Fragoso JM; Vargas Alarcón G; Maldonado Murillo K; Rivas Jiménez ML; Barbosa Cobos RE; Jimenez Morales S; Lugo Zamudio G; Tovilla Zárate C; Ramírez Bello J
Rheumatol Int; 2016 Feb; 36(2):249-54. PubMed ID: 26350270
[TBL] [Abstract][Full Text] [Related]
3. Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations.
Orozco G; Robledo G; Linga Reddy MV; García A; Pascual-Salcedo D; Balsa A; González-Gay MA; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; Petersson IF; Alarcón-Riquelme M; Martín J
Rheumatology (Oxford); 2006 Nov; 45(11):1442-4. PubMed ID: 16935917
[No Abstract] [Full Text] [Related]
4. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
Harrison P; Pointon JJ; Farrar C; Harin A; Wordsworth BP
Rheumatology (Oxford); 2007 Mar; 46(3):409-11. PubMed ID: 16920747
[TBL] [Abstract][Full Text] [Related]
5. The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.
Yazdani-Biuki B; Brickmann K; Wohlfahrt K; Mueller T; März W; Renner W; Gutjahr M; Langsenlehner U; Krippl P; Wascher TC; Paulweber B; Graninger W; Brezinschek HP
Arthritis Res Ther; 2006; 8(4):R97. PubMed ID: 16776848
[TBL] [Abstract][Full Text] [Related]
6. Association between the functional MHC2TA -168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Clin Rheumatol; 2016 Apr; 35(4):901-9. PubMed ID: 26439834
[TBL] [Abstract][Full Text] [Related]
7. Role of the MHC2TA gene in autoimmune diseases.
Martínez A; Sánchez-Lopez M; Varadé J; Mas A; Martín MC; de Las Heras V; Arroyo R; Mendoza JL; Díaz-Rubio M; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
Ann Rheum Dis; 2007 Mar; 66(3):325-9. PubMed ID: 17012290
[TBL] [Abstract][Full Text] [Related]
8. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.
Bronson PG; Criswell LA; Barcellos LF
Ann Rheum Dis; 2008 Jul; 67(7):933-6. PubMed ID: 17875550
[TBL] [Abstract][Full Text] [Related]
9. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Swanberg M; Lidman O; Padyukov L; Eriksson P; Akesson E; Jagodic M; Lobell A; Khademi M; Börjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
Nat Genet; 2005 May; 37(5):486-94. PubMed ID: 15821736
[TBL] [Abstract][Full Text] [Related]
10. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.
Dieguez-Gonzalez R; Akar S; Calaza M; Gonzalez-Alvaro I; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Caliz R; Blanco FJ; Pascual-Salcedo D; Velloso ML; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Lopez-Longo FJ; Herrero-Beaumont G; Gomez-Reino JJ; Gonzalez A
J Rheumatol; 2009 Aug; 36(8):1590-5. PubMed ID: 19567623
[TBL] [Abstract][Full Text] [Related]
11. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort.
Eyre S; Bowes J; Spreckley K; Potter C; Ring S; Strachan D; Worthington J; Barton A
Arthritis Rheum; 2006 Nov; 54(11):3417-22. PubMed ID: 17075826
[TBL] [Abstract][Full Text] [Related]
13. A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis.
Plant D; Barton A; Thomson W; Ke X; Eyre S; Hinks A; Bowes J; Gibbons LJ; Wilson AG; Marinou I; Morgan AW; Steer S; Hocking LJ; Reid DM; Wordsworth P; Harrison P; Worthington J
Ann Rheum Dis; 2009 Aug; 68(8):1373-5. PubMed ID: 19605748
[No Abstract] [Full Text] [Related]
14. Promoter activity of A/G at position -168 in the type III promoter of MHCIITA gene.
Okamoto H; Kaneko H; Terai C; Kamatani N
Rheumatology (Oxford); 2008 Apr; 47(4):547-8. PubMed ID: 18256035
[No Abstract] [Full Text] [Related]
15. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies.
O'Doherty C; Hawkins S; Rooney M; Vandenbroeck K
Tissue Antigens; 2007 Sep; 70(3):247-51. PubMed ID: 17661914
[TBL] [Abstract][Full Text] [Related]
16. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
[TBL] [Abstract][Full Text] [Related]
17. CIITA gene polymorphism (rs3087456) in systemic lupus erythematosus and rheumatoid arthritis: A population-based cohort study.
Lima SC; Gomes da Silva IIF; Nascimento DQ; de Moura RR; Mesquita MDS; Asano NMJ; Fernandes GV; Valente LM; Rushansky E; Mariano MHQA; Xavier RM; Chies JAB; Crovella S; Sandrin-Garcia P
Int J Immunogenet; 2021 Oct; 48(5):429-434. PubMed ID: 34180145
[TBL] [Abstract][Full Text] [Related]
18. Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus.
Sánchez E; Sabio JM; Jiménez-Alonso J; Callejas JL; Camps M; de Ramón E; García-Portales R; de Haro M; Ortego-Centeno N; López-Nevot MA; Martín J
Rheumatology (Oxford); 2008 Jan; 47(1):102-3. PubMed ID: 17956914
[No Abstract] [Full Text] [Related]
19. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
20. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Pecori Giraldi F; Terzolo M; Betterle C; Falorni A
J Clin Endocrinol Metab; 2006 Oct; 91(10):4107-11. PubMed ID: 16849401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
